Opens in a new tab

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Featured

June
26
2026
{post_date: F d, Y}

Turning ECG Data into Actionable Insight with AI

For decades, the ECG has been a fundamental yet relatively limited diagnostic tool in cardiovascular medicine. However, AI-enabled technologies are shifting this paradigm by extracting layers of hidden biological signals…
February
01
2026
{post_date: F d, Y}

Anumana Makes Educated Inferences in Heart Failure

Anumana was founded in 2021 as the culmination of a joint effort between the Mayo Clinic and nference, an early entrant to the field of machine learning for cardiology-focused clinical…
November
26
2025
{post_date: F d, Y}

Supporting Predictive Analytics to Improve Clinical Decision Making and Patient Outcomes

As we strive to improve clinical decison making and patient outcomes – predictive analytics are a wonderful tool to help us in that goal. But you can’t just decide to throw predictive analytics into…
April
22
2025
{post_date: F d, Y}

Cardiology’s AI Moment: Anumana’s Top Insights from ACC.25

#TeamAnumana wrapped up three incredible days of exploring cardiovascular science in the Windy City at the American College of Cardiology’s Annual Scientific Session. ACC.25 brought together thousands of cardiologists, investigators,…